37 During cancer development, iron metabolism is usually changed at both the cellular and systemic levels
Understanding your condition and treatment options is key to effective management
Tirzepatide can cause temporary amenorrhea (loss of menstruation) due to rapid weight loss and reduced estrogen levels, a condition called hypothalamic amenorrhea
However, more pronounced and sustained weight loss results are generally observed after approximately 12 weeks of continuous treatment, with peak outcomes often achieved between 6 to 12 months
926 Hepatic hepcidin expression is significantly reduced, and iron homeostasis is altered in hepatic Hdac3 -specific knockout mice ( Hdac3 -LKO mice)
Methods: We searched PubMed, Scopus, Cochrane Library, Google Scholar, and Web of Science (ClinicalTrials.gov for unpublished records) from their inception to 5 February 2025, including observational cohort studies and randomized controlled trials